Biotech group Actelion, Johnson & Johnson confirm deal talks

By Paul Arnold and Ludwig Burger ZURICH/FRANKFURT (Reuters) - U.S. healthcare group Johnson & Johnson (J&J) and biotech group Actelion confirmed they are in talks after media reports about a potential deal sent the Swiss company's stock to a record high. Shares in Actelion had jumped as much as 19 percent on the reports that a takeover may be brewing for the fast-growing biotechnology group. "Actelion confirmed today that it has been approached by Johnson & Johnson about a possible t